Cargando…

Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease

OBJECTIVES: To examine the frequency and risk factors of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND). METHODS: This was an observational study of 100 ALS/MND patients treated at our hospital outpatient and inpatient departm...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Fang, Zhu, Wenjia, Zhou, Zhibin, Ren, Yuting, Li, Yifan, Li, Mao, Huo, Yunyun, Huang, Xusheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639547/
https://www.ncbi.nlm.nih.gov/pubmed/26604769
http://dx.doi.org/10.2147/NDT.S90520
_version_ 1782399934513807360
author Cui, Fang
Zhu, Wenjia
Zhou, Zhibin
Ren, Yuting
Li, Yifan
Li, Mao
Huo, Yunyun
Huang, Xusheng
author_facet Cui, Fang
Zhu, Wenjia
Zhou, Zhibin
Ren, Yuting
Li, Yifan
Li, Mao
Huo, Yunyun
Huang, Xusheng
author_sort Cui, Fang
collection PubMed
description OBJECTIVES: To examine the frequency and risk factors of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND). METHODS: This was an observational study of 100 ALS/MND patients treated at our hospital outpatient and inpatient departments between January 2009 and April 2010 and 100 matched healthy controls. Subjects were surveyed using Mini Mental State Examination (MMSE), Zung Self-Rating Anxiety Scale (SAS), and Zung Self-Rating Depression Scale (SDS). Patient neurological status was graded by the ALS Functional Rating Scale (ALSFRS). Multivariate linear regression was used to identify factors associated with the MMSE, SAS, SDS, and ALSFRS scores. RESULTS: Patients had significantly lower MMSE scores than controls (P<0.05). MMSE score did not differ by sex or age (<50/≥50 years) (P>0.05). Patients with higher educational level (college and above), shorter disease course (<2 years), and lower ALSFRS score (<20) had significantly higher MMSE scores (all P<0.05). Multivariate analysis revealed that higher education, shorter disease course, and lower ALSFRS score were independent predictors of better cognitive function (higher MMSE score). Patients had significantly higher mean SAS and SDS total scores than controls (both P<0.05), indicating higher subjective anxiety and depression. Female patients, patients with higher education, and those with higher ALSFRS scores had significantly higher SAS and SDS scores (all P<0.05). Age, occupation, diagnostic classification, disease duration, and disease awareness did not influence SAS or SDS scores. Multivariate analysis indicated that lower education and lower ALSFRS were protective factors against anxiety and depression. CONCLUSION: The frequency of anxiety-depressive disorders was high among patients with ALS/MND. High educational level, short course of disease, and lower ALSFRS were associated with preserved cognitive function. Female sex, higher education, and lower ALSFRS score conferred a greater risk of anxiety and depression. Tailored pharmacotherapy and psychological interventions may help in reducing anxiety and depression in these patients.
format Online
Article
Text
id pubmed-4639547
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-46395472015-11-24 Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease Cui, Fang Zhu, Wenjia Zhou, Zhibin Ren, Yuting Li, Yifan Li, Mao Huo, Yunyun Huang, Xusheng Neuropsychiatr Dis Treat Original Research OBJECTIVES: To examine the frequency and risk factors of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND). METHODS: This was an observational study of 100 ALS/MND patients treated at our hospital outpatient and inpatient departments between January 2009 and April 2010 and 100 matched healthy controls. Subjects were surveyed using Mini Mental State Examination (MMSE), Zung Self-Rating Anxiety Scale (SAS), and Zung Self-Rating Depression Scale (SDS). Patient neurological status was graded by the ALS Functional Rating Scale (ALSFRS). Multivariate linear regression was used to identify factors associated with the MMSE, SAS, SDS, and ALSFRS scores. RESULTS: Patients had significantly lower MMSE scores than controls (P<0.05). MMSE score did not differ by sex or age (<50/≥50 years) (P>0.05). Patients with higher educational level (college and above), shorter disease course (<2 years), and lower ALSFRS score (<20) had significantly higher MMSE scores (all P<0.05). Multivariate analysis revealed that higher education, shorter disease course, and lower ALSFRS score were independent predictors of better cognitive function (higher MMSE score). Patients had significantly higher mean SAS and SDS total scores than controls (both P<0.05), indicating higher subjective anxiety and depression. Female patients, patients with higher education, and those with higher ALSFRS scores had significantly higher SAS and SDS scores (all P<0.05). Age, occupation, diagnostic classification, disease duration, and disease awareness did not influence SAS or SDS scores. Multivariate analysis indicated that lower education and lower ALSFRS were protective factors against anxiety and depression. CONCLUSION: The frequency of anxiety-depressive disorders was high among patients with ALS/MND. High educational level, short course of disease, and lower ALSFRS were associated with preserved cognitive function. Female sex, higher education, and lower ALSFRS score conferred a greater risk of anxiety and depression. Tailored pharmacotherapy and psychological interventions may help in reducing anxiety and depression in these patients. Dove Medical Press 2015-11-03 /pmc/articles/PMC4639547/ /pubmed/26604769 http://dx.doi.org/10.2147/NDT.S90520 Text en © 2015 Cui et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Cui, Fang
Zhu, Wenjia
Zhou, Zhibin
Ren, Yuting
Li, Yifan
Li, Mao
Huo, Yunyun
Huang, Xusheng
Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
title Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
title_full Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
title_fullStr Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
title_full_unstemmed Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
title_short Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
title_sort frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639547/
https://www.ncbi.nlm.nih.gov/pubmed/26604769
http://dx.doi.org/10.2147/NDT.S90520
work_keys_str_mv AT cuifang frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease
AT zhuwenjia frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease
AT zhouzhibin frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease
AT renyuting frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease
AT liyifan frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease
AT limao frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease
AT huoyunyun frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease
AT huangxusheng frequencyandriskfactoranalysisofcognitiveandanxietydepressivedisordersinpatientswithamyotrophiclateralsclerosismotorneurondisease